Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.03 a new company low.

Within Major Pharmaceutical Preparations industry 438 other companies have achieved higher Quick Ratio than Shuttle Pharmaceuticals Holdings Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3710, from total ranking in the first quarter 2026 at 5062.

Explain Quick Ratio?
How much Cash & cash equivalents SHPH�s has?
What are SHPH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SHPH Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	105.62 %	366.03 %	419.42 %	18.42 %	22.26 %
Y / Y Cash & cash equivalent Change	-97.88 %	-75.85 %	-82.61 %	1237.1 %	106.01 %
Quick Ratio MRQ	0.03	0.13	0.04	1.07	2.85
SHPH's Total Ranking	# 3710	# 5062	# 2207	# 1303	# 1422
Seq. Current Liabilities Change	-58.09 %	4.25 %	305.46 %	16.07 %	-5.02 %
Seq. Cash & cash equivalent Change	-90.62 %	226.33 %	-84.05 %	-56.52 %	6.76 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 439
Healthcare Sector	# 890
Overall Market	# 4200

Quick Ratio Statistics
High	Average	Low
16.92	3.14	0.03
(Jun 30 2023)

Financial Statements
Shuttle Pharmaceuticals Holdings Inc 's Current Liabilities	$ 3 Millions	Visit SHPH's Balance sheet
Shuttle Pharmaceuticals Holdings Inc 's Cash & cash equivalent	$ 0 Millions	Visit SHPH's Balance sheet
Source of SHPH's Sales		Visit SHPH's Sales by Geography

Cumulative Shuttle Pharmaceuticals Holdings Inc 's Quick Ratio

SHPH's Quick Ratio for the trailling 12 Months

SHPH Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	225.71 %	213.38 %	120.99 %	13 %	25.28 %
Y / Y Cash & cash equivalent TTM Growth	-68.26 %	-6.63 %	36.68 %	9.87 %	-39.31 %
Quick Ratio TTM	0.17	0.42	0.88	1.91	1.71
Total Ranking TTM	# 2169	# 1646	# 631	# 718	# 1041
Seq. Current Liabilities TTM Growth	8.97 %	48.66 %	92.25 %	4.58 %	4.85 %
Seq. Cash & cash equivalent TTM Growth	-56.57 %	-29.11 %	-11.89 %	16.99 %	27.77 %

Quick ratio ranking by company, industry and sector >> Back to SHPH Financial Strength Comparisons >> Go to Compare SHPH Quick Ratio to its Competitors

On the trailing twelve months basis Due to drop in Current Liabilities in the Q2 2026 to $3.48 millions, cumulative Quick Ratio decreased to 0.17 below the Shuttle Pharmaceuticals Holdings Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Shuttle Pharmaceuticals Holdings Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 4065.

Explain Quick Ratio?
How much Cash & cash equivalents SHPH�s has?
What are SHPH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 443
Healthcare Sector	# 909
Within the Market	# 3710

trailing twelve months Quick Ratio Statistics
High	Average	Low
7.88	2.72	0.16
(Jun 30 2023)		(Sep 30 2017)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Cv Sciences Inc	0.05	$ 0.266 Millions	$ 4.943 Millions
Citius Pharmaceuticals Inc	0.05	$ 17.008 Millions	$ 333.952 Millions
Sunshine Biopharma Inc	0.05	$ 0.281 Millions	$ 5.619 Millions
Hcw Biologics Inc	0.04	$ 0.741 Millions	$ 18.648 Millions
China Pharma Holdings Inc	0.04	$ 0.305 Millions	$ 7.682 Millions
Bioxytran Inc	0.03	$ 0.177 Millions	$ 5.275 Millions
Cdt Equity Inc	0.03	$ 0.700 Millions	$ 23.351 Millions
Shuttle Pharmaceuticals Holdings Inc	0.03	$ 0.102 Millions	$ 3.481 Millions
Northwest Biotherapeutics Inc	0.01	$ 0.595 Millions	$ 42.982 Millions
Oncotelic Therapeutics Inc	0.01	$ 0.186 Millions	$ 17.907 Millions
Os Therapies Incorporated	0.01	$ 0.205 Millions	$ 20.653 Millions
The Greater Cannabis Company Inc	0.01	$ 0.000 Millions	$ 0.012 Millions
Chemocentryx Inc.	0.01	$ 1.253 Millions	$ 139.868 Millions
NIKA PHARMACEUTICALS, INC	0.01	$ 0.003 Millions	$ 0.341 Millions
Evofem Biosciences Inc	0.01	$ 0.714 Millions	$ 88.615 Millions

Date modified: 2026-09-25T05:02:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.